MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$255,843K
EPS
-$4.22
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
214,712
General and administrative
70,883
Total operating expenses
285,595
Loss from operations
-285,595
Interest income, net
30,030
Total other income, net
30,030
Net loss before taxes
-255,565
Provision for income taxes
278
Net loss after taxes
-255,843
Basic EPS
-4.22
Diluted EPS
-4.22
Basic Average Shares
60,690,820
Diluted Average Shares
60,690,820
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss after taxes-$255,843K Interest income, net$30,030K Net loss beforetaxes-$255,565K Provision for income taxes$278K Total other income,net$30,030K Loss from operations-$285,595K Total operatingexpenses$285,595K Research and development$214,712K General andadministrative$70,883K

Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. (APGE)